A beloved company that has been part of the fabric of the US and has served hundreds of millions of customers around the ...

Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...